Prudential PLC Completion of Share Buyback Programme

RNS Number : 2675O

Prudential PLC

29 November 2024

 

Prudential plc

 

Completion of Share Repurchase Programme to neutralise 2024 share issuance for Scrip dividend and Employee share scheme

 

Prudential plc (the "Company") confirms that the share repurchase programme that was announced on 22 November 2024 and commenced on 25 November 2024 (the "Programme") has now completed.

 

Since the commencement of the Programme, the Company has repurchased 2,814,023 ordinary shares in aggregate at a volume weighted average price of 648.2889 pence per ordinary share for a total consideration of approximately £18.2m.

 

Additional information

 

About Prudential plc

 

Prudential plc provides life and health insurance and asset management in 24 markets across Asia and Africa. Prudential's mission is to be the most trusted partner and protector for this generation and generations to come, by providing simple and accessible financial and health solutions. The business has dual primary listings on the Stock Exchange of Hong Kong (2378) and the London Stock Exchange (PRU). It also has a secondary listing on the Singapore Stock Exchange (K6S) and a listing on the New York Stock Exchange (PUK) in the form of American Depositary Receipts. It is a constituent of the Hang Seng Composite Index and is also included for trading in the Shenzhen-Hong Kong Stock Connect programme and the Shanghai-Hong Kong Stock Connect programme.

 

Prudential is not affiliated in any manner with Prudential Financial, Inc. a company whose principal place of business is in the United States of America, nor with The Prudential Assurance Company Limited, a subsidiary of M&G plc, a company incorporated in the United Kingdom.

 

https://www.prudentialplc.com/

 

 

Contact

 

Media		Investors/Analysts
Simon Kutner	[phone]	Patrick Bowes	[phone]
Sonia Tsang	[phone]	William Elderkin	[phone]
		Darwin Lam	[phone]

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCQKCBPOBDDNDB